Journal article
Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma
Abstract
BACKGROUND: Omalizumab is indicated for the treatment of moderate to severe asthma. There is limited observational evidence on the costs and effectiveness of omalizumab.
OBJECTIVE: To examine the costs and effectiveness of omalizumab for treatment of severe asthma relative to nonusers.
Authors
Tadrous M; Khuu W; Lebovic G; Stanbrook MB; Martins D; Paterson JM; Mamdani MM; Juurlink DN; Gomes T
Journal
Annals of Allergy Asthma & Immunology, Vol. 120, No. 1, pp. 59–65.e2
Publisher
Elsevier
Publication Date
January 2018
DOI
10.1016/j.anai.2017.08.016
ISSN
1081-1206